The CACNA1A Foundation has joined the Rare Patient Network, powered by Citizen Health, a next generation digital Natural History Study that organizes, summarizes and stores patient medical record information obtained from multiple hospitals and providers.

Important information that can accelerate research is often trapped in medical records. As a patient or parent/guardian, you can unlock those records and contribute them to research in a private and secure way.

Citizen is a natural history study that uses medical records across multiple hospitals and providers where a participant has been seen, rather than patient/parent/caregiver reported data, to collect meaningful information on how a mutation in the CACNA1A gene has affected a person’s life.

ADVANTAGES to Citizen Health:

  • Participation is completely digital

  • Collects participants’ medical records from all institutions visited

  • Say goodbye to the binder - data from medical records is organized and summarized in a secure digital account at no cost to you

  • The participant retains full control over medical records

  • Easy access to your medical records and they can be easily shared with new providers or to solicit second opinions with the click of a button

  • Having all medical records in one place helps you gain control and have a better understanding of your medical history

  • You can have a big impact on research with minimal effort! With your consent, clinicians, researchers and biopharma can access anonymized data to aid in research.

Why Natural History Studies Matter?

Natural History Studies (NHS) are critical to the drug development process. Citizen Health has developed a new method to make this process easier. A next-generation, digital NHS for CACNA1A-related disorders is expected to facilitate:

  • Informing clinical researchers how a disease changes over time

  • Enabling better endpoint selection to use in clinical trials

  • Understanding the connection between mutation types and symptoms 

  • Reducing the time it takes to study new medicines in clinical trials

  • Speeding up the time to get therapeutics to patients

  • Using data as a placebo (instead of actual patients) in a clinical trial

Become a CACNA1A Citizen and help advance research and accelerate the path to treatments

In order to be eligible to participate, you must have had a seizure onset of any kind before the age of 18 OR a current diagnosis or history of developmental delay/IDD AND be receiving medical treatment in the USA

Frequently Asked Questions:

Learn More About Citizen Health and How to Enroll